Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Case methodology disclosed Health Canada reviewed 15 cases of suicide, self-harm and suicidal/self-harm ideation in patients using GLP-1 RAs, including 3 Canadian and 12 international reports, with 2 drawn from published literature
Its worth noting that only Zepbound is FDA-approved for weight loss, while Mounjaro may be prescribed off-label for this purpose
Semaglutide is a GLP-1 receptor agonist, while tirzepatide targets two pathways (GLP-1 and GIP)
Our semaglutide and tirzepatide injections help our clients effectively lose weightbut its not a miracle cure
It is a microbiome-mediated GLP-1 optimisation strategy
